624 related articles for article (PubMed ID: 8537166)
1. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
Stein ME; Lachter J; Spencer D; Bezwoda WR
Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
[TBL] [Abstract][Full Text] [Related]
2. Epidemic AIDS-related Kaposi's sarcoma in southern Africa: experience at the Johannesburg General Hospital (1980-1990).
Stein ME; Spencer D; Kantor A; Ruff P; Haim N; Bezwoda WR
Trans R Soc Trop Med Hyg; 1994; 88(4):434-6. PubMed ID: 7570833
[TBL] [Abstract][Full Text] [Related]
3. Variants of Kaposi's sarcoma in Southern Africa. A retrospective analysis (1980-1992).
Stein ME; Lachter J; Spencer D; Margolius L; Bezwoda WR
Acta Oncol; 1996; 35(2):193-9. PubMed ID: 8639315
[TBL] [Abstract][Full Text] [Related]
4. Etoposide, vincristine, doxorubicin and dexamethasone (EVAD) combination chemotherapy as second-line treatment for advanced AIDS-related Kaposi's sarcoma.
Zhong DT; Shi CM; Chen Q; Huang JZ; Liang JG; Lin D
J Cancer Res Clin Oncol; 2012 Mar; 138(3):425-30. PubMed ID: 22160130
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
Gill PS; Wernz J; Scadden DT; Cohen P; Mukwaya GM; von Roenn JH; Jacobs M; Kempin S; Silverberg I; Gonzales G; Rarick MU; Myers AM; Shepherd F; Sawka C; Pike MC; Ross ME
J Clin Oncol; 1996 Aug; 14(8):2353-64. PubMed ID: 8708728
[TBL] [Abstract][Full Text] [Related]
6. Increased risk for opportunistic infections during chemotherapy in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; van Dyk U; Stoehr A; Albrecht H; Stellbrink HJ; Berger J; Meigel W
Dermatology; 1997; 194(3):234-7. PubMed ID: 9187839
[TBL] [Abstract][Full Text] [Related]
7. Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial.
Krown SE; Moser CB; MacPhail P; Matining RM; Godfrey C; Caruso SR; Hosseinipour MC; Samaneka W; Nyirenda M; Busakhala NW; Okuku FM; Kosgei J; Hoagland B; Mwelase N; Oliver VO; Burger H; Mngqibisa R; Nokta M; Campbell TB; Borok MZ;
Lancet; 2020 Apr; 395(10231):1195-1207. PubMed ID: 32145827
[TBL] [Abstract][Full Text] [Related]
8. Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine.
Laubenstein LJ; Krigel RL; Odajnyk CM; Hymes KB; Friedman-Kien A; Wernz JC; Muggia FM
J Clin Oncol; 1984 Oct; 2(10):1115-20. PubMed ID: 6208343
[TBL] [Abstract][Full Text] [Related]
9. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
Cochrane Database Syst Rev; 2014 Aug; 8(8):CD003256. PubMed ID: 25221796
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome.
Gelmann EP; Longo D; Lane HC; Fauci AS; Masur H; Wesley M; Preble OT; Jacob J; Steis R
Am J Med; 1987 Mar; 82(3):456-62. PubMed ID: 2435150
[TBL] [Abstract][Full Text] [Related]
11. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.
Schalling M; Ekman M; Kaaya EE; Linde A; Biberfeld P
Nat Med; 1995 Jul; 1(7):707-8. PubMed ID: 7585156
[TBL] [Abstract][Full Text] [Related]
12. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
Cochrane Database Syst Rev; 2014; (9):CD003256. PubMed ID: 25313415
[TBL] [Abstract][Full Text] [Related]
13. The role of chemotherapy for epidemic Kaposi's sarcoma.
Volberding PA
Semin Oncol; 1987 Jun; 14(2 Suppl 3):23-6. PubMed ID: 2440109
[TBL] [Abstract][Full Text] [Related]
14. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
15. Treatment of classical type Kaposi's sarcoma with paclitaxel.
Chao SC; Lee JY; Tsao CJ
Anticancer Res; 2001; 21(1B):571-3. PubMed ID: 11299806
[TBL] [Abstract][Full Text] [Related]
16. Effects on pulmonary function of two regimens of chemotherapy for AIDS related Kaposi's sarcoma.
Denton AS; Simpson JK; Hallam M; Spittle MF; Miller RF
Clin Oncol (R Coll Radiol); 1996; 8(1):48-50. PubMed ID: 8688362
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy in epidemic, AIDS-related Kaposi's sarcoma in southern Africa.
Stein M; Spencer D; Kantor A; Lakier R; Lachter J; Ben-Yosef R; Bezwoda WR
Tumori; 1994 Jun; 80(3):216-9. PubMed ID: 7519802
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy.
Northfelt DW; Dezube BJ; Thommes JA; Levine R; Von Roenn JH; Dosik GM; Rios A; Krown SE; DuMond C; Mamelok RD
J Clin Oncol; 1997 Feb; 15(2):653-9. PubMed ID: 9053490
[TBL] [Abstract][Full Text] [Related]
19. Experience with adriamycin, bleomycin, vincristine (ABV) palliative chemotherapy in advanced AIDS-related Kaposi's sarcoma.
Paparizos VA; Kyriakis KP; Mileounis KA; Pfandl-Polydorou D; Stavrianeas NG; Vareltzidis AG; Stratigos JD
J Chemother; 1996 Oct; 8(5):403-6. PubMed ID: 8957723
[TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine.
Gill P; Rarick M; Bernstein-Singer M; Harb M; Espina BM; Shaw V; Levine A
Am J Clin Oncol; 1990 Aug; 13(4):315-9. PubMed ID: 1696066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
